{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:30:01Z","timestamp":1791225001164,"version":"4.1.0"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T00:00:00Z","timestamp":1388016000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"DOI":"10.1371\/journal.ppat.1003852","type":"journal-article","created":{"date-parts":[[2013,12,26]],"date-time":"2013-12-26T21:55:36Z","timestamp":1388094936000},"page":"e1003852","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":37,"title":["The CD8-Derived Chemokine XCL1\/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1"],"prefix":"10.1371","volume":"9","author":[{"given":"Christina","family":"Guzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaello","family":"Cimbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian F.","family":"Volkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony S.","family":"Fauci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Lusso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,12,26]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.4049\/jimmunol.144.8.2961","article-title":"CD8+ T cells inhibit HIV replication in naturally infected CD4+ T cells. Evidence for a soluble inhibitor","volume":"144","author":"JE Brinchmann","year":"1990","journal-title":"J Immunol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"F Cocchi","year":"1995","journal-title":"Science"},{"key":"ref3","first-page":"628","article-title":"A diffusible lymphokine produced by CD8+ T lymphocytes suppresses HIV replication","volume":"66","author":"CM Walker","year":"1989","journal-title":"Immunology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1126\/science.2431484","article-title":"CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication","volume":"234","author":"CM Walker","year":"1986","journal-title":"Science"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0008-8749(89)90259-1","article-title":"CD8+ T lymphocyte control of HIV replication in cultured CD4+ cells varies among infected individuals","volume":"119","author":"CM Walker","year":"1989","journal-title":"Cell Immunol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1073\/pnas.1202240109","article-title":"Soluble factors from T cells inhibiting X4 strains of HIV are a mixture of beta chemokines and RNases","volume":"109","author":"F Cocchi","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrmicro878","article-title":"Control of HIV-1 infection by soluble factors of the immune response","volume":"2","author":"AL DeVico","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1089\/aid.1995.11.1321","article-title":"Suppression of activation of the human immunodeficiency virus long terminal repeat by CD8+ T cells is not lentivirus specific","volume":"11","author":"KF Copeland","year":"1995","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1073\/pnas.92.6.2308","article-title":"CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription","volume":"92","author":"CE Mackewicz","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1089\/aid.1993.9.1079","article-title":"CD8+ T lymphocyte-mediated inhibition of HIV-1 long terminal repeat transcription: a novel antiviral mechanism","volume":"9","author":"CH Chen","year":"1993","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0022034511399081","article-title":"Innate immunity and HIV-1 infection","volume":"23","author":"T Lehner","year":"2011","journal-title":"Adv Dent Res"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1172\/JCI2323","article-title":"Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro","volume":"102","author":"A Oliva","year":"1998","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/rmv.369","article-title":"The influence of cytokines, chemokines and their receptors on HIV-1 replication in monocytes and macrophages","volume":"13","author":"K Kedzierska","year":"2003","journal-title":"Rev Med Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"9569","DOI":"10.1073\/pnas.1207314109","article-title":"Identification of the platelet-derived chemokine CXCL4\/PF-4 as a broad-spectrum HIV-1 inhibitor","volume":"109","author":"DJ Auerbach","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0709518105","article-title":"Interconversion between two unrelated protein folds in the lymphotactin native state","volume":"105","author":"RL Tuinstra","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/sj.emboj.7600947","article-title":"HIV and the chemokine system: 10 years later","volume":"25","author":"P Lusso","year":"2006","journal-title":"EMBO J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/eji.1830250638","article-title":"Cloning of ATAC, an activation-induced, chemokine-related molecule exclusively expressed in CD8+ T lymphocytes","volume":"25","author":"S Muller","year":"1995","journal-title":"Eur J Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/cyto.2001.0944","article-title":"Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells","volume":"16","author":"I Tikhonov","year":"2001","journal-title":"Cytokine"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1128\/JVI.74.18.8358-8367.2000","article-title":"Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120","volume":"74","author":"CA Derdeyn","year":"2000","journal-title":"J Virol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/JVI.72.4.2855-2864.1998","article-title":"Effects of CCR5 and CD4 cell surface concentrations on infections by macrophagetropic isolates of human immunodeficiency virus type 1","volume":"72","author":"EJ Platt","year":"1998","journal-title":"J Virol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1128\/AAC.46.6.1896-1905.2002","article-title":"Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy","volume":"46","author":"X Wei","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1021\/bi602365d","article-title":"An engineered second disulfide bond restricts lymphotactin\/XCL1 to a chemokine-like conformation with XCR1 agonist activity","volume":"46","author":"RL Tuinstra","year":"2007","journal-title":"Biochemistry"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"12598","DOI":"10.1074\/jbc.M311633200","article-title":"Identification and characterization of a glycosaminoglycan recognition element of the C chemokine lymphotactin","volume":"279","author":"FC Peterson","year":"2004","journal-title":"J Biol Chem"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1128\/JVI.73.8.6370-6379.1999","article-title":"The CC-chemokine RANTES increases the attachment of human immunodeficiency virus type 1 to target cells via glycosaminoglycans and also activates a signal transduction pathway that enhances viral infectivity","volume":"73","author":"A Trkola","year":"1999","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/3293","article-title":"Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry","volume":"4","author":"JM Kilby","year":"1998","journal-title":"Nat Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.micinf.2011.10.003","article-title":"XCL1 and XCR1 in the immune system","volume":"14","author":"Y Lei","year":"2012","journal-title":"Microbes Infect"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.bbrc.2010.06.029","article-title":"Conservation of a chemokine system, XCR1 and its ligand, XCL1, between human and mice","volume":"397","author":"C Yamazaki","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"Pt 9","key":"ref28","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1099\/0022-1317-80-9-2369","article-title":"Sensitivity of human immunodeficiency virus infection to various alpha, beta and gamma chemokines","volume":"80","author":"G Greco","year":"1999","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/QAD.0b013e328326cc0d","article-title":"Broad usage spectrum of G protein-coupled receptors as coreceptors by primary isolates of HIV","volume":"23","author":"N Shimizu","year":"2009","journal-title":"AIDS"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.immuni.2009.08.027","article-title":"Selective expression of the chemokine receptor XCR1 on cross-presenting dendritic cells determines cooperation with CD8+ T cells","volume":"31","author":"BG Dorner","year":"2009","journal-title":"Immunity"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/viro.1994.1141","article-title":"An N-glycan within the human immunodeficiency virus type 1 gp120 V3 loop affects virus neutralization","volume":"199","author":"NK Back","year":"1994","journal-title":"Virology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF01310789","article-title":"Identification of an N-linked glycan in the V1-loop of HIV-1 gp120 influencing neutralization by anti-V3 antibodies and soluble CD4","volume":"139","author":"GJ Gram","year":"1994","journal-title":"Arch Virol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.10.005","article-title":"Modified HIV envelope proteins with enhanced binding to neutralizing monoclonal antibodies","volume":"331","author":"SM Kang","year":"2005","journal-title":"Virology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1128\/JVI.01691-07","article-title":"Removal of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responses","volume":"82","author":"Y Li","year":"2008","journal-title":"J Virol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1128\/JVI.76.9.4199-4211.2002","article-title":"Role of N-linked glycans in a human immunodeficiency virus envelope glycoprotein: effects on protein function and the neutralizing antibody response","volume":"76","author":"MI Quinones-Kochs","year":"2002","journal-title":"J Virol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.virol.2004.03.022","article-title":"HIV-1 acute infection env glycomutants designed from 3D model: effects on processing, antigenicity, and neutralization sensitivity","volume":"324","author":"F Reynard","year":"2004","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/31405","article-title":"Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody","volume":"393","author":"PD Kwong","year":"1998","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/JVI.02054-06","article-title":"Type-specific epitopes targeted by monoclonal antibodies with exceptionally potent neutralizing activities for selected strains of human immunodeficiency virus type 1 map to a common region of the V2 domain of gp120 and differ only at single positions from the clade B consensus sequence","volume":"81","author":"WJ Honnen","year":"2007","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6909","DOI":"10.1128\/JVI.79.11.6909-6917.2005","article-title":"The C108g epitope in the V2 domain of gp120 functions as a potent neutralization target when introduced into envelope proteins derived from human immunodeficiency virus type 1 primary isolates","volume":"79","author":"A Pinter","year":"2005","journal-title":"J Virol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1126\/science.1178746","article-title":"Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target","volume":"326","author":"LM Walker","year":"2009","journal-title":"Science"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.febslet.2004.11.062","article-title":"Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro","volume":"579","author":"Z Wu","year":"2005","journal-title":"FEBS Lett"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.str.2010.09.017","article-title":"Crystal structure of HIV-1 primary receptor CD4 in complex with a potent antiviral antibody","volume":"18","author":"MM Freeman","year":"2010","journal-title":"Structure"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jim.2005.05.008","article-title":"Glycosylated recombinant human XCL1\/lymphotactin exhibits enhanced biologic activity","volume":"302","author":"C Dong","year":"2005","journal-title":"J Immunol Methods"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/AAC.49.11.4721-4732.2005","article-title":"Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity","volume":"49","author":"P Dorr","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1096\/fj.10-167627","article-title":"Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity","volume":"25","author":"P Lusso","year":"2011","journal-title":"FASEB J"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1016\/j.vaccine.2007.12.023","article-title":"Rational design of novel HIV-1 entry inhibitors by RANTES engineering","volume":"26","author":"L Vangelista","year":"2008","journal-title":"Vaccine"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/13543770903575674","article-title":"Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006\u20132008","volume":"20","author":"H Yang","year":"2010","journal-title":"Expert Opin Ther Pat"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1038\/nm1196-1240","article-title":"The role of a mutant CCR5 allele in HIV-1 transmission and disease progression","volume":"2","author":"Y Huang","year":"1996","journal-title":"Nat Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ng0597-100","article-title":"Global distribution of the CCR5 gene 32-basepair deletion","volume":"16","author":"JJ Martinson","year":"1997","journal-title":"Nat Genet"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.virusres.2007.10.006","article-title":"HIV-1 p17 binds heparan sulfate proteoglycans to activated CD4(+) T cells","volume":"132","author":"C Poiesi","year":"2008","journal-title":"Virus Res"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e22081","DOI":"10.1371\/journal.pone.0022081","article-title":"Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4","volume":"6","author":"SE Burastero","year":"2011","journal-title":"PLoS One"}],"container-title":["PLoS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.ppat.1003852","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,9]],"date-time":"2023-07-09T08:58:59Z","timestamp":1688893139000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1003852"}},"subtitle":[],"editor":[{"given":"Alexandra","family":"Trkola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,12,26]]},"references-count":51,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2013,12,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1003852","relation":{},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,26]]}}}